Amgen Inc

Healthcare · Drug Manufacturers - General

418.10$ +0.8% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Amgen Inc (AMGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 36,741 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AMGN
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2,198	2,346	2,642	3,204	3,448	4,016	5,523	8,356	10,550	12,430	14,268	14,771	15,003	14,642	15,053	15,582	17,265	18,676	20,063	21,662	22,991	22,849	23,747	23,362	25,424	25,979	26,323	28,190	33,424	36,741
Cost of Revenue	183	184	201	225	197	443	736	1,341	1,731	2,082	2,095	2,548	2,296	2,091	2,220	2,427	2,918	3,346	4,422	4,227	4,162	4,069	4,101	4,356	6,159	6,454	6,406	8,451	12,858	10,729
Gross Profit	2,015	2,162	2,441	2,979	3,252	3,573	4,787	7,015	8,819	10,348	12,173	12,223	12,707	12,551	12,833	13,155	14,347	15,330	15,641	17,435	18,829	18,780	19,646	19,006	19,265	19,525	19,917	19,739	20,566	26,012
Research & Development	528	631	663	823	845	865	1,117	1,655	2,028	2,314	3,366	3,266	3,030	2,864	2,894	3,167	3,380	4,083	4,297	4,070	3,840	3,562	3,737	4,116	4,207	6,324	4,434	4,784	5,964	6,974
Selling, General & Administrative	471	484	515	654	827	971	1,462	1,953	2,556	2,790	3,366	3,361	3,789	3,820	3,983	4,486	4,801	5,184	4,699	4,509	4,631	4,250	4,658	4,361	4,768	4,525	4,573	5,477	6,109	2,460
Total Operating Expenses	1,099	1,232	1,323	1,654	1,884	2,042	5,572	3,924	5,471	5,500	8,333	8,243	7,493	7,045	7,288	8,562	8,489	9,463	9,450	8,965	9,035	8,807	9,383	9,332	10,126	11,886	10,351	11,842	13,308	15,336
Operating Income	916	930	1,118	1,325	1,368	1,531	-785	3,091	3,348	4,848	3,840	3,980	5,214	5,506	5,545	4,312	5,577	5,867	6,191	8,470	9,794	9,973	10,263	9,674	9,139	7,639	9,566	7,897	7,258	10,676
Interest Expense	99	134	222	409	482	202	12,834	102	1,061	29	2,282	2,136	551	578	604	610	1,053	1,022	1,071	1,095	1,260	1,304	1,392	1,289	1,262	1,197	1,406	2,875	3,155	2,755
Pre-Tax Income	962	861	1,224	1,566	1,674	1,686	-685	3,173	3,395	4,868	4,020	3,961	5,250	5,204	5,317	4,150	5,009	5,265	5,585	7,978	9,163	9,597	9,545	9,138	8,133	6,701	7,346	7,855	4,609	8,976
Income Tax Expense	283	217	361	470	536	567	707	914	1,032	1,194	1,070	795	1,054	599	690	467	664	184	427	1,039	1,441	7,618	1,151	1,296	869	808	794	1,138	519	1,265
Net Income	680	644	863	1,096	1,139	1,120	-1,392	2,260	2,363	3,674	2,950	3,166	4,196	4,605	4,627	3,683	4,345	5,081	5,158	6,939	7,722	1,979	8,394	7,842	7,264	5,893	6,552	6,717	4,090	7,711
EBITDA	1,016	1,047	1,262	1,502	1,580	1,797	2,654	3,778	4,636	5,689	6,034	5,981	6,639	6,831	6,938	5,820	7,150	7,573	8,748	11,181	12,528	12,856	12,883	12,633	12,996	11,296	12,169	7,897	13,356	16,898

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings